KZR
Kezar Life Sciences
KZR
KZR
Delisted
KZR was delisted on the 8th of May, 2026.
About: Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Employees: 9
Price charts implemented using
Lightweight Charts™